logo

Arbutus Biopharma Corp. (ABUS)



Trade ABUS now with
  Date
  Headline
3/19/2018 1:34:51 PM Wedbush Is Raising Arbutus Biopharma Corp. (ABUS) 2018 Estimate To -1.33 From -1.54
3/19/2018 1:34:37 PM Wedbush Is Increasing Arbutus Biopharma Corp. (ABUS) 4Q18 Estimate To -0.34 From -0.40
3/19/2018 1:34:20 PM Wedbush Is Raising Arbutus Biopharma Corp. (ABUS) 3Q18 Estimate To -0.34 From -0.39
3/19/2018 1:33:55 PM Wedbush Is Increasing Arbutus Biopharma Corp. (ABUS) 2Q18 Estimate To -0.33 From -0.38
3/19/2018 1:33:39 PM Wedbush Is Increasing Arbutus Biopharma Corp. (ABUS) 1Q18 Estimate To -0.32 From -0.37
3/19/2018 9:30:05 AM Wedbush Downgrades Arbutus Biopharma Corp. (ABUS) To Neutral From Outperform With $6 Down From $9 Price Target
2/22/2018 4:57:08 PM Arbutus Biopharma Settles Litigation; Acuitas Has No Further Rights To Use Or Sublicense Arbutus LNP Technology
2/13/2018 9:49:13 PM Arbutus Biopharma EVP And CFO Bruce Cousins To Step Down; Names Koert VandenEnden Interim CFO
1/5/2018 1:21:09 PM B. Riley FBR Initiates Arbutus Biopharma Corp. (ABUS) At Buy With $10.00 Price Target
11/3/2017 2:07:56 PM Wedbush Is Lowering Arbutus Biopharma Corp. (ABUS) 2018 Rev. Estimate To 0.0 M From 2.6 M
11/3/2017 2:07:34 PM Wedbush Is Cutting Arbutus Biopharma Corp. (ABUS) 4Q18 Rev. Estimate To 0.0 M From 0.7 M
11/3/2017 5:34:15 AM ABUS Is Abuzz...
10/16/2017 10:33:44 AM Arbutus Closes $50 Mln First Tranche Of $116.4 Mln Strategic Investment From Roivant Sciences
10/2/2017 7:08:46 AM Arbutus Biopharma To Get $116 Mln Strategic Investment From Roivant Sciences